<?xml version="1.0" encoding="UTF-8"?><measure><measureDetails><uuid>40280381-4b9a-3825-014b-dc0a24b30faa</uuid><title>Chlamydia Screening for Women</title><shortTitle>Chlamydia</shortTitle><emeasureid>153</emeasureid><guid>c9930664-be3d-4ffe-ae4a-5cf4933ecb89</guid><version>4.0.000</version><nqfid extension="0033" root="2.16.840.1.113883.3.560.1"/><period calenderYear="true" uuid="40280381-3d61-56a7-013e-5d40019f6c0f"><startDate>00000101</startDate><stopDate>00001231</stopDate></period><steward id="2.16.840.1.113883.3.464">National Committee for Quality Assurance</steward><developers><developer id="2.16.840.1.113883.3.464">National Committee for Quality Assurance</developer></developers><endorsement id="2.16.840.1.113883.3.560">National Quality Forum</endorsement><description>Percentage of women 16-24 years of age who were identified as sexually active and who had at least one test for chlamydia during the measurement period.</description><copyright>Physician Performance Measure (Measures) and related data specifications were developed by the National Committee for Quality Assurance (NCQA). &#xD;
&#xD;
The Measures are copyrighted but can be reproduced and distributed, without modification, for noncommercial purposes (eg, use by healthcare providers in connection with their practices). Commercial use is defined as the sale, licensing, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain. Commercial use of the Measures requires a license agreement between the user and NCQA. NCQA is not responsible for any use of the Measures. &#xD;
&#xD;
(c) 2008-2015 National Committee for Quality Assurance. All Rights Reserved. &#xD;
&#xD;
Limited proprietary coding is contained in the Measure specifications for user convenience. Users of proprietary code sets should obtain all necessary licenses from the owners of the code sets. NCQA disclaims all liability for use or accuracy of any CPT or other codes contained in the specifications.&#xD;
&#xD;
CPT(R) contained in the Measure specifications is copyright 2004-2014 American Medical Association. LOINC(R) copyright 2004-2014 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2014 International Health Terminology Standards Development Organisation. ICD-10 copyright 2014 World Health Organization. All Rights Reserved.</copyright><disclaimer>These performance Measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications.&#xD;
&#xD;
THE MEASURES AND SPECIFICATIONS ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND.&#xD;
&#xD;
Due to technical limitations, registered trademarks are indicated by (R) or [R] and unregistered trademarks are indicated by (TM) or [TM].</disclaimer><scoring id="PROPOR">Proportion</scoring><types><type id="PROCESS">Process</type></types><componentMeasures/><itemCount/><stratification>Report a total score, and each of the following strata:&#xD;
Stratum 1: Patients age 16-20 &#xD;
Stratum 2: Patients age 21-24</stratification><riskAdjustment>None</riskAdjustment><aggregation>None</aggregation><rationale>Chlamydia trachomatis is the most common sexually transmitted bacterial infection in the U.S., resulting in over 2.8 million new cases each year (Centers for Disease Control and Prevention 2011 - Chlamydia).  It is often known as a "silent" disease because most infected people have no symptoms and therefore are unaware they have an infection (United States Preventive Services Task Force, 2007; Centers for Disease Control and Prevention 2011- Chlamydia). Although chlamydia symptoms are usually mild or nonexistent, untreated infections can lead to serious and irreversible complications (United States Preventive Services Task Force 2007).&#xD;
&#xD;
Women are particularly vulnerable when infected with chlamydia. Left untreated, chlamydia can cause pelvic inflammatory disease (PID), permanent damage to a woman's fallopian tubes, uterus and surrounding tissue, or Reiter Syndrome, which includes pink eye (conjunctivitis) and skin lesions affecting the lower extremities. Between 10 and 15 percent of untreated chlamydia infections result in PID, which can lead to ectopic pregnancy and infertility (Centers for Disease Control and Prevention 2011 - Chlamydia). As many as 15 percent of women with PID will become infertile (Centers for Disease Control and Prevention 2011 - Pelvic Inflammatory Disease). Additionally, pregnant women might experience premature delivery, miscarriage, low birth weight, infant mortality, or they may pass conjunctivitis or chlamydia pneumonia to their infants (United States Preventive Services Task Force, 2007; Centers for Disease Control and Prevention 2011-Chlamydia). Chlamydia is the leading cause of preventable infertility and, among other adverse pregnancy related problems, can cause preterm birth, miscarriages, infant mortality, and neonatal chlamydia infections (United States Preventive Services Task Force 2007).&#xD;
&#xD;
Over 900,000 chlamydia infections were reported to the Centers for Disease Control and Prevention (CDC) from 50 states and the District of Columbia in 2004. Since many cases are not reported or even diagnosed, it is estimated that there are actually 2.8 million new cases of chlamydia each year (Centers for Disease Control and Prevention 2010). From 1987 through 2004, the reported rate of chlamydia infection in women increased from 78.5 cases to 485 cases per 100,000 people, though a portion of the increase in prevalence is attributed to continued expansion of chlamydia screening programs (Centers for Disease Control and Prevention 2005).&#xD;
&#xD;
A significant proportion of sexually active individuals, both male and female, continue to go undiagnosed due to the disease's asymptomatic nature (Wilson et al. 2009). Approximately 75 percent of chlamydia infections in women and 95 percent in men are asymptomatic, resulting in delayed medical care and treatment (Centers for Disease Control and Prevention 2011 - Pelvic Inflammatory Disease). Women whose sexual partners are not screened and appropriately treated are at high risk for re-infection. Multiple chlamydia infections increase a woman's risk of serious reproductive health complications (Centers for Disease Control and Prevention 2010).</rationale><recommendations>U.S. Preventive Services Task Force (2007):&#xD;
All sexually active nonpregnant young women age 24 years or younger and older women (pregnant or not) who are at increased risk should be screened for a chlamydial infection. &#xD;
&#xD;
The USPSTF found fair evidence that nucleic acid amplification tests (NAATs) can identify chlamydial infection in asymptomatic men and women, including asymptomatic pregnant women, with high test specificity. &#xD;
&#xD;
If clinicians have not concurrently screened for chlamydial infection, the CDC recommends presumptive treatment for chlamydia at the time of treatment for gonorrhea. In order to prevent recurrent transmission, partners of infected individuals should be tested and treated if infected, or treated presumptively.  &#xD;
&#xD;
American Academy of Family Physicians (2009):&#xD;
The AAFP strongly recommends screening for chlamydia infection for all sexually active non-pregnant young women aged 24 and younger and for older non-pregnant women who are at increased risk. &#xD;
&#xD;
The AAFP recommends screening for chlamydia infection for all pregnant women aged 24 younger and for older pregnant women who are at increased risk.</recommendations><improvementNotations>Higher score indicates better quality</improvementNotations><references><reference>Centers for Disease Control and Prevention. 2011. "Chlamydia - CDC Fact Sheet." http://www.cdc.gov/std/Chlamydia/STDFact-Chlamydia.htm</reference><reference>United States Preventive Services Task Force. 2007. Screening for chlamydia infection: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 147(2):128-34. </reference><reference>Wilson, T.E., M. Hogben, E.S. Malka, N. Liddon, W.M. McCormack, S.R. Rubin, M.A. Augenbraun. 2009. "A Randomized Controlled Trial for Reducing Risks for Sexually Transmitted Infections Through Enhanced Patient-Based Partner Notification." Am J Public Health 99(S1):S104-10.</reference><reference>Centers for Disease Control and Prevention. 2011. "Pelvic Inflammatory Disease (PID) - CDC Fact Sheet"  http://www.cdc.gov/std/PID/STDFact-PID.htm </reference><reference>Centers for Disease Control and Prevention. 2010. "Sexually Transmitted Diseases (STDs): Chlamydia Treatment." http://www.cdc.gov/std/chlamydia/treatment.htm (June 6, 2011).</reference><reference>Centers for Disease Control and Prevention. 2005. Sexually Transmitted Disease Surveillance 2004 Supplement, Chlamydia Prevalence Monitoring Project. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.</reference><reference>American Academy of Family Physicians (AAFP). 2009. Summary of recommendations for clinical preventive services. Revision 6.8. Leawood: American Academy of Family Physicians (AAFP).</reference></references><definitions>None</definitions><guidance>Codes to identify sexually active women include codes for: pregnancy, sexually transmitted infections, contraceptives or contraceptive devices, and infertility treatments.&#xD;
&#xD;
The denominator exclusion does not apply to patients who qualify for the initial population (IP) based on services other than the pregnancy test alone. For example, a patient who has both a pregnancy test and a chlamydia diagnosis, either of which would qualify them for the IP, would not be eligible for this denominator exclusion.</guidance><transmissionFormat>TBD</transmissionFormat><initialPopDescription>Women 16 to 24 years of age who are sexually active and who had a visit in the measurement period</initialPopDescription><denominatorDescription>Equals Initial Population</denominatorDescription><denominatorExclusionsDescription>Women who received a pregnancy test solely as a safety precaution before ordering an x-ray or specified medications</denominatorExclusionsDescription><numeratorDescription>Women with at least one chlamydia test during the measurement period</numeratorDescription><numeratorExclusionsDescription>Not Applicable</numeratorExclusionsDescription><denominatorExceptionsDescription>None</denominatorExceptionsDescription><measurePopulationDescription>Not applicable</measurePopulationDescription><measurePopulationExclusionsDescription>Not applicable</measurePopulationExclusionsDescription><measureObservationsDescription>Not applicable</measureObservationsDescription><supplementalData>For every patient evaluated by this measure also identify payer, race, ethnicity and sex.</supplementalData><qualityMeasureSet uuid="dab47982-50b7-4f66-9000-c98f6de6f953">None</qualityMeasureSet>
<finalizedDate value="201503302138-0500"/>
</measureDetails><supplementalDataElements><elementRef id="40280381-3d61-56a7-013e-5d40019e6c0a" name="ONC Administrative Sex"/><elementRef id="40280381-3d61-56a7-013e-5d40019e6c0b" name="Race"/><elementRef id="40280381-3d61-56a7-013e-5d40019e6c0c" name="Ethnicity"/><elementRef id="40280381-3d61-56a7-013e-5d40019f6c0d" name="Payer"/></supplementalDataElements><riskAdjustmentVariables/><subTreeLookUp><subTree displayName="Age GtEq 16" qdmVariable="false" uuid="C36E32FA-F492-48B7-B797-7F6D42951025"><functionalOp displayName="Age &gt;= 16 years at" operatorType="Greater Than or Equal To" quantity="16" type="AGE AT" unit="years"><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-5d40019f6c0f" type="qdm"/></functionalOp></subTree><subTree displayName="Age Lt 24" qdmVariable="false" uuid="5DEECF3C-0982-43D1-B07D-F993D31E3EA7"><functionalOp displayName="Age &lt; 24 years at" operatorType="Less Than" quantity="24" type="AGE AT" unit="years"><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-5d40019f6c0f" type="qdm"/></functionalOp></subTree><subTree displayName="Female" qdmVariable="false" uuid="79030A79-C8D8-449E-A56C-9945EB12C850"><elementRef displayName="Female : Patient Characteristic Sex" id="40280381-3d61-56a7-013e-5d4001a06c25" type="qdm"/></subTree><subTree displayName="IP Encounter" qdmVariable="false" uuid="D87C5F5D-24C0-4F9A-BFF8-046C2DB48A11"><relationalOp displayName="During" type="DURING"><setOp displayName="UNION" type="union"><elementRef displayName="Office Visit : Encounter, Performed" id="40280381-3d61-56a7-013e-5d4001a06c2d" type="qdm"/><elementRef displayName="Face-to-Face Interaction : Encounter, Performed" id="40280381-3d61-56a7-013e-5d4001a06c2e" type="qdm"/><elementRef displayName="Preventive Care Services - Established Office Visit, 18 and Up : Encounter, Performed" id="40280381-3d61-56a7-013e-5d4001a06c2f" type="qdm"/><elementRef displayName="Preventive Care Services-Initial Office Visit, 18 and Up : Encounter, Performed" id="40280381-3d61-56a7-013e-5d4001a06c30" type="qdm"/><elementRef displayName="Preventive Care - Established Office Visit, 0 to 17 : Encounter, Performed" id="40280381-3d61-56a7-013e-5d4001a06c32" type="qdm"/><elementRef displayName="Preventive Care- Initial Office Visit, 0 to 17 : Encounter, Performed" id="40280381-3d61-56a7-013e-5d4001a06c33" type="qdm"/><elementRef displayName="Home Healthcare Services : Encounter, Performed" id="40280381-3d61-56a7-013e-5d4001a06c31" type="qdm"/></setOp><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-5d40019f6c0f" type="qdm"/></relationalOp></subTree><subTree displayName="STD Diagnoses or Contraceptive Med Overlap Measurement Period" qdmVariable="false" uuid="8F475B96-9543-41F0-BA1C-37745AA9C7FE"><relationalOp displayName="Overlaps" type="Overlap"><setOp displayName="UNION" type="union"><elementRef displayName="Other Female Reproductive Conditions : Diagnosis, Active" id="40280381-3d61-56a7-013e-5d40019f6c11" type="qdm"/><elementRef displayName="Genital Herpes : Diagnosis, Active" id="40280381-3d61-56a7-013e-5d40019f6c12" type="qdm"/><elementRef displayName="Gonococcal Infections and Venereal Diseases : Diagnosis, Active" id="40280381-3d61-56a7-013e-5d40019f6c16" type="qdm"/><elementRef displayName="Contraceptive Medications : Medication, Active" id="40280381-3d61-56a7-013e-5d40019f6c21" type="qdm"/><elementRef displayName="Inflammatory Diseases of Female Reproductive Organs : Diagnosis, Active" id="40280381-3d61-56a7-013e-5d40019f6c13" type="qdm"/><elementRef displayName="Chlamydia : Diagnosis, Active" id="40280381-3d61-56a7-013e-5d40019f6c14" type="qdm"/><elementRef displayName="HIV : Diagnosis, Active" id="40280381-3d61-56a7-013e-5d40019f6c18" type="qdm"/><elementRef displayName="Syphilis : Diagnosis, Active" id="40280381-3d61-56a7-013e-5d40019f6c15" type="qdm"/><elementRef displayName="Complications of Pregnancy, Childbirth and the Puerperium : Diagnosis, Active" id="40280381-3d61-56a7-013e-5d40019f6c17" type="qdm"/></setOp><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-5d40019f6c0f" type="qdm"/></relationalOp></subTree><subTree displayName="Orders or Px Performed During MP" qdmVariable="false" uuid="0878D710-84D1-4F63-9018-45C8C7868E84"><relationalOp displayName="During" type="DURING"><setOp displayName="UNION" type="union"><elementRef displayName="Pregnancy Test : Laboratory Test, Order" id="40280381-3d61-56a7-013e-5d4001a06c29" type="qdm"/><elementRef displayName="Pap Test : Laboratory Test, Order" id="40280381-3d61-56a7-013e-5d4001a06c27" type="qdm"/><elementRef displayName="Delivery Live Births : Procedure, Performed" id="40280381-3d61-56a7-013e-5d40019f6c1f" type="qdm"/><elementRef displayName="Lab Tests During Pregnancy : Laboratory Test, Order" id="40280381-3d61-56a7-013e-5d4001a06c2b" type="qdm"/><elementRef displayName="Lab Tests for Sexually Transmitted Infections : Laboratory Test, Order" id="40280381-3d61-56a7-013e-5d4001a06c2c" type="qdm"/><elementRef displayName="Contraceptive Medications : Medication, Order" id="40280381-3d61-56a7-013e-5d4001a06c2a" type="qdm"/><elementRef displayName="Diagnostic Studies During Pregnancy : Diagnostic Study, Order" id="40280381-3d61-56a7-013e-5d4001a06c28" type="qdm"/><elementRef displayName="Procedures During Pregnancy : Procedure, Performed" id="40280381-3d61-56a7-013e-5d40019f6c1d" type="qdm"/><elementRef displayName="Procedures Involving Contraceptive Devices : Procedure, Performed" id="40280381-3d61-56a7-013e-5d40019f6c1e" type="qdm"/></setOp><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-5d40019f6c0f" type="qdm"/></relationalOp></subTree><subTree displayName="Orders during Occ A Preg Test Lab Order" qdmVariable="false" uuid="842052A6-1F2C-414A-B5A9-3FE91351295B"><relationalOp displayName="&lt;= 7 days Starts After End Of" operatorType="Less Than or Equal To" quantity="7" type="SAE" unit="days"><setOp displayName="UNION" type="union"><elementRef displayName="Isotretinoin : Medication, Order" id="40280381-3d61-56a7-013e-5d4001a06c26" type="qdm"/><elementRef displayName="X-Ray Study (all inclusive) : Diagnostic Study, Order" id="40280381-3d61-56a7-013e-5d4001a06c35" type="qdm"/></setOp><elementRef displayName="Occurrence A of Pregnancy Test : Laboratory Test, Order" id="40280381-3d61-56a7-013e-5d4001a06c34" type="qdm"/></relationalOp></subTree><subTree displayName="Chlamydia Screening Lab Result" qdmVariable="false" uuid="5A8D47FB-6081-45B7-A2FA-458730201FA8"><relationalOp displayName="During" type="DURING"><elementRef displayName="Chlamydia Screening : Laboratory Test, Performed" id="8fc8c808-85a3-4528-8a52-3d0475977cc2" type="qdm"><attribute attrUUID="210cfba6-43d7-471d-9799-fca572b7cb8d" mode="Check if Present" name="result"/></elementRef><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-5d40019f6c0f" type="qdm"/></relationalOp></subTree><subTree displayName="Occ A Preg Test Lab Test Order During MP" qdmVariable="false" uuid="A70C2FCC-2740-498E-8499-AAEDE79BB161"><relationalOp displayName="During" type="DURING"><elementRef displayName="Occurrence A of Pregnancy Test : Laboratory Test, Order" id="40280381-3d61-56a7-013e-5d4001a06c34" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-5d40019f6c0f" type="qdm"/></relationalOp></subTree><subTree displayName="Age GtEq 20" qdmVariable="false" uuid="1F6B76BC-685B-4AF0-BEB2-4ED3F7AB8934"><functionalOp displayName="Age &gt;= 20 years at" operatorType="Greater Than or Equal To" quantity="20" type="AGE AT" unit="years"><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-5d40019f6c0f" type="qdm"/></functionalOp></subTree><subTree displayName="Age less than or equal 19" qdmVariable="false" uuid="A04F4603-AC18-4CEE-86C7-2BE660EF518A"><functionalOp displayName="Age &lt;= 19 years at" operatorType="Less Than or Equal To" quantity="19" type="AGE AT" unit="years"><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-5d40019f6c0f" type="qdm"/></functionalOp></subTree></subTreeLookUp><measureGrouping><group sequence="1"><clause displayName="Initial Population 1" type="initialPopulation" uuid="2645D2CB-710C-4748-B871-A2968AD0ACEF"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Age GtEq 16" id="C36E32FA-F492-48B7-B797-7F6D42951025" type="subTree"/><subTreeRef displayName="Age Lt 24" id="5DEECF3C-0982-43D1-B07D-F993D31E3EA7" type="subTree"/><subTreeRef displayName="Female" id="79030A79-C8D8-449E-A56C-9945EB12C850" type="subTree"/><subTreeRef displayName="IP Encounter" id="D87C5F5D-24C0-4F9A-BFF8-046C2DB48A11" type="subTree"/><logicalOp displayName="OR" type="or"><subTreeRef displayName="STD Diagnoses or Contraceptive Med Overlap Measurement Period" id="8F475B96-9543-41F0-BA1C-37745AA9C7FE" type="subTree"/><subTreeRef displayName="Orders or Px Performed During MP" id="0878D710-84D1-4F63-9018-45C8C7868E84" type="subTree"/></logicalOp></logicalOp></clause><clause displayName="Denominator 1" type="denominator" uuid="9978D424-48E7-48AC-BC36-DD68BFE9E56C"><logicalOp displayName="AND" type="and"/></clause><clause displayName="Denominator Exclusions 1" type="denominatorExclusions" uuid="420FBBEE-3312-4793-9874-71CF56631D8C"><logicalOp displayName="OR" type="or"><comment displayName="comment" type="comment"/><logicalOp displayName="AND" type="and"><comment displayName="comment" type="comment"/><subTreeRef displayName="Occ A Preg Test Lab Test Order During MP" id="A70C2FCC-2740-498E-8499-AAEDE79BB161" type="subTree"/><subTreeRef displayName="Orders during Occ A Preg Test Lab Order" id="842052A6-1F2C-414A-B5A9-3FE91351295B" type="subTree"/></logicalOp></logicalOp></clause><clause displayName="Numerator 1" type="numerator" uuid="BFADD7FB-BE49-4FEC-9A1B-1FF82D02DA97"><logicalOp displayName="AND" type="and"><comment displayName="comment" type="comment"/><subTreeRef displayName="Chlamydia Screening Lab Result" id="5A8D47FB-6081-45B7-A2FA-458730201FA8" type="subTree"/></logicalOp></clause><clause displayName="Stratum 1" type="stratum" uuid="7398F106-ACC4-4CC3-BE5A-E7F939E8D562"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Age GtEq 16" id="C36E32FA-F492-48B7-B797-7F6D42951025" type="subTree"/><subTreeRef displayName="Age less than or equal 19" id="A04F4603-AC18-4CEE-86C7-2BE660EF518A" type="subTree"/></logicalOp></clause><clause displayName="Stratum 2" type="stratum" uuid="33A7DA86-1326-4A38-B8F8-51088EAA7836"><logicalOp displayName="AND" type="and"><comment displayName="comment" type="comment"/><subTreeRef displayName="Age GtEq 20" id="1F6B76BC-685B-4AF0-BEB2-4ED3F7AB8934" type="subTree"/><subTreeRef displayName="Age Lt 24" id="5DEECF3C-0982-43D1-B07D-F993D31E3EA7" type="subTree"><comment displayName="comment" type="comment"/></subTreeRef></logicalOp></clause><clause displayName="numeratorExclusions" type="numeratorExclusions" uuid="57ae0b4a-5acd-4f70-85e0-d9b2c7077381"><logicalOp displayName="AND" type="and"/></clause><clause displayName="denominatorExceptions" type="denominatorExceptions" uuid="5b9d5fe5-ceb0-4e2c-b6fa-3e6ab414c120"><logicalOp displayName="AND" type="and"/></clause></group></measureGrouping><elementLookUp><qdm datatype="Patient Characteristic Birthdate" id="ad096571-d1b2-4a05-baba-4d0ff8d15675" name="Birthdate" oid="21112-8" suppDataElement="false" taxonomy="SNOMED-CT" uuid="ad096571-d1b2-4a05-baba-4d0ff8d15675" version="1.0"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Diagnosis, Active" id="40280381-3d61-56a7-013e-5d40019f6c14" name="Chlamydia" oid="2.16.840.1.113883.3.464.1003.112.12.1003" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d40019f6c14" version="1"/><qdm datatype="Laboratory Test, Performed" id="8fc8c808-85a3-4528-8a52-3d0475977cc2" name="Chlamydia Screening" oid="2.16.840.1.113883.3.464.1003.110.12.1052" suppDataElement="false" taxonomy="Grouping" uuid="8fc8c808-85a3-4528-8a52-3d0475977cc2" version="1.0"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Diagnosis, Active" id="40280381-3d61-56a7-013e-5d40019f6c17" name="Complications of Pregnancy, Childbirth and the Puerperium" oid="2.16.840.1.113883.3.464.1003.111.12.1012" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d40019f6c17" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Medication, Active" id="40280381-3d61-56a7-013e-5d40019f6c21" name="Contraceptive Medications" oid="2.16.840.1.113883.3.464.1003.196.12.1080" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d40019f6c21" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Medication, Order" id="40280381-3d61-56a7-013e-5d4001a06c2a" name="Contraceptive Medications" oid="2.16.840.1.113883.3.464.1003.196.12.1080" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d4001a06c2a" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Procedure, Performed" id="40280381-3d61-56a7-013e-5d40019f6c1f" name="Delivery Live Births" oid="2.16.840.1.113883.3.464.1003.111.12.1015" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d40019f6c1f" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Diagnostic Study, Order" id="40280381-3d61-56a7-013e-5d4001a06c28" name="Diagnostic Studies During Pregnancy" oid="2.16.840.1.113883.3.464.1003.111.12.1008" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d4001a06c28" version="1"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Ethnicity" id="40280381-3d61-56a7-013e-5d40019e6c0c" name="Ethnicity" oid="2.16.840.1.114222.4.11.837" suppDataElement="true" taxonomy="CDCREC" uuid="40280381-3d61-56a7-013e-5d40019e6c0c" version="1"/><qdm datatype="Patient Characteristic Expired" id="3b85612b-8ce9-493b-b7e9-ae794d409116" name="Expired" oid="419099009" suppDataElement="false" taxonomy="SNOMED-CT" uuid="3b85612b-8ce9-493b-b7e9-ae794d409116" version="1.0"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3d61-56a7-013e-5d4001a06c2e" name="Face-to-Face Interaction" oid="2.16.840.1.113883.3.464.1003.101.12.1048" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d4001a06c2e" version="1"/><qdm codeSystemName="National Quality Forum" datatype="Patient Characteristic Sex" id="40280381-3d61-56a7-013e-5d4001a06c25" name="Female" oid="2.16.840.1.113883.3.560.100.2" suppDataElement="false" taxonomy="AdministrativeSex" uuid="40280381-3d61-56a7-013e-5d4001a06c25" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Diagnosis, Active" id="40280381-3d61-56a7-013e-5d40019f6c12" name="Genital Herpes" oid="2.16.840.1.113883.3.464.1003.110.12.1049" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d40019f6c12" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Diagnosis, Active" id="40280381-3d61-56a7-013e-5d40019f6c16" name="Gonococcal Infections and Venereal Diseases" oid="2.16.840.1.113883.3.464.1003.112.12.1001" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d40019f6c16" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Diagnosis, Active" id="40280381-3d61-56a7-013e-5d40019f6c18" name="HIV" oid="2.16.840.1.113883.3.464.1003.120.12.1003" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d40019f6c18" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3d61-56a7-013e-5d4001a06c31" name="Home Healthcare Services" oid="2.16.840.1.113883.3.464.1003.101.12.1016" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d4001a06c31" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Diagnosis, Active" id="40280381-3d61-56a7-013e-5d40019f6c13" name="Inflammatory Diseases of Female Reproductive Organs" oid="2.16.840.1.113883.3.464.1003.112.12.1004" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d40019f6c13" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Medication, Order" id="40280381-3d61-56a7-013e-5d4001a06c26" name="Isotretinoin" oid="2.16.840.1.113883.3.464.1003.196.12.1143" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d4001a06c26" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Laboratory Test, Order" id="40280381-3d61-56a7-013e-5d4001a06c2b" name="Lab Tests During Pregnancy" oid="2.16.840.1.113883.3.464.1003.111.12.1007" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d4001a06c2b" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Laboratory Test, Order" id="40280381-3d61-56a7-013e-5d4001a06c2c" name="Lab Tests for Sexually Transmitted Infections" oid="2.16.840.1.113883.3.464.1003.110.12.1051" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d4001a06c2c" version="1"/><qdm codeSystemName="National Quality Forum" datatype="Timing Element" id="40280381-3d61-56a7-013e-5d40019f6c0f" name="Measurement Period" oid="2.16.840.1.113883.3.67.1.101.1.53" suppDataElement="false" taxonomy="NQF" uuid="40280381-3d61-56a7-013e-5d40019f6c0f" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3d61-56a7-013e-5d4001a06c2d" name="Office Visit" oid="2.16.840.1.113883.3.464.1003.101.12.1001" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d4001a06c2d" version="1"/><qdm codeSystemName="National Library of Medicine" datatype="Patient Characteristic Sex" id="40280381-3d61-56a7-013e-5d40019e6c0a" name="ONC Administrative Sex" oid="2.16.840.1.113762.1.4.1" suppDataElement="true" taxonomy="AdministrativeGender" uuid="40280381-3d61-56a7-013e-5d40019e6c0a" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Diagnosis, Active" id="40280381-3d61-56a7-013e-5d40019f6c11" name="Other Female Reproductive Conditions" oid="2.16.840.1.113883.3.464.1003.111.12.1006" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d40019f6c11" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Laboratory Test, Order" id="40280381-3d61-56a7-013e-5d4001a06c27" name="Pap Test" oid="2.16.840.1.113883.3.464.1003.108.12.1017" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d4001a06c27" version="1"/><qdm codeSystemName="PHDSC" datatype="Patient Characteristic Payer" id="40280381-3d61-56a7-013e-5d40019f6c0d" name="Payer" oid="2.16.840.1.114222.4.11.3591" suppDataElement="true" taxonomy="SOP" uuid="40280381-3d61-56a7-013e-5d40019f6c0d" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Laboratory Test, Order" id="40280381-3d61-56a7-013e-5d4001a06c34" instance="Occurrence A" name="Pregnancy Test" oid="2.16.840.1.113883.3.464.1003.111.12.1011" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d4001a06c34" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3d61-56a7-013e-5d4001a06c32" name="Preventive Care - Established Office Visit, 0 to 17" oid="2.16.840.1.113883.3.464.1003.101.12.1024" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d4001a06c32" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3d61-56a7-013e-5d4001a06c2f" name="Preventive Care Services - Established Office Visit, 18 and Up" oid="2.16.840.1.113883.3.464.1003.101.12.1025" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d4001a06c2f" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3d61-56a7-013e-5d4001a06c30" name="Preventive Care Services-Initial Office Visit, 18 and Up" oid="2.16.840.1.113883.3.464.1003.101.12.1023" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d4001a06c30" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3d61-56a7-013e-5d4001a06c33" name="Preventive Care- Initial Office Visit, 0 to 17" oid="2.16.840.1.113883.3.464.1003.101.12.1022" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d4001a06c33" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Procedure, Performed" id="40280381-3d61-56a7-013e-5d40019f6c1d" name="Procedures During Pregnancy" oid="2.16.840.1.113883.3.464.1003.111.12.1009" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d40019f6c1d" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Procedure, Performed" id="40280381-3d61-56a7-013e-5d40019f6c1e" name="Procedures Involving Contraceptive Devices" oid="2.16.840.1.113883.3.464.1003.111.12.1010" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d40019f6c1e" version="1"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Race" id="40280381-3d61-56a7-013e-5d40019e6c0b" name="Race" oid="2.16.840.1.114222.4.11.836" suppDataElement="true" taxonomy="CDCREC" uuid="40280381-3d61-56a7-013e-5d40019e6c0b" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Diagnosis, Active" id="40280381-3d61-56a7-013e-5d40019f6c15" name="Syphilis" oid="2.16.840.1.113883.3.464.1003.112.12.1002" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d40019f6c15" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Diagnostic Study, Order" id="40280381-3d61-56a7-013e-5d4001a06c35" name="X-Ray Study (all inclusive)" oid="2.16.840.1.113883.3.464.1003.198.12.1034" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d4001a06c35" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Laboratory Test, Order" id="40280381-3d61-56a7-013e-5d4001a06c29" name="Pregnancy Test" oid="2.16.840.1.113883.3.464.1003.111.12.1011" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-5d4001a06c29" version="1"/></elementLookUp></measure>